Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC399

Rimegepant eða lyfjafræðilega viðunandi salt þar af

  • Status:
    Veitt
  • Application date:
    3.8.2022
  • Application published:
    15.9.2022
  • Grant published:
    15.1.2025
  • Max expiry date:
    12.10.2035
  • Medicine name:
    Vydura
  • Medicine for children:
    No

Timeline

Today
3.8.2022Application
15.9.2022Publication
15.1.2025Registration
12.10.2035Expires

Marketing license

  • IS authorization number:
    EU/1/22/1645/001-002
  • Date:
    11.5.2022
  • Foreign authorization number:
    EU/1/22/1645
  • Date:
    25.4.2022

Owner

  • Name:
    Bristol­Myers Squibb Company
  • Address:
    Route 206 & Province Line Road, Princeton, NJ 08543-­4000 US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 09.01.2025

Upload documents